ALDX
Aldeyra Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.12
-0.55 ▼ -11.67%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$4.32
+0.20 ▲ +4.73%
| Index | RUT | P/E | - | EPS (ttm) | -0.56 | Insider Own | 7.49% | Shs Outstand | 0.06B | Perf Week | -14.06% |
| Market Cap | 0.25B | Forward P/E | 15.87 | EPS next Y | 44.44% | Insider Trans | - | Shs Float | 0.06B | Perf Month | -22.46% |
| Enterprise Value | 0.19B | PEG | - | EPS next Q | -0.09 | Inst Own | 65.12% | Short Float | 9.44% | Perf Quarter | -13.88% |
| Income | -0.03B | P/S | - | EPS this Y | 131.3% | Inst Trans | 6.13% | Short Ratio | 4.77 | Perf Half Y | -25.81% |
| Sales | 0.00B | P/B | 5.61 | EPS next 5Y | - | ROA | -38.32% | Short Interest | 5.25M | Perf YTD | -20.37% |
| Book/sh | 0.74 | P/C | 3.54 | EPS past 3/5Y | 19.04% 12.61% | ROE | -58.73% | 52W High | -42.23% ($7.14) | Perf Year | -39.43% |
| Cash/sh | 1.16 | P/FCF | - | Sales past 3/5Y | - | ROIC | -76.49% | 52W Low | 261.84% ($1.14) | Perf 3Y | -41.24% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 39.96% | Gross Margin | - | Volatility(W/M) | 11.97% 8.05% | Perf 5Y | -67.05% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.43 | Perf 10Y | -3.85% |
| Dividend Ex-Date | - | Quick Ratio | 2.54 | EPS Q/Q | 59.53% | Profit Margin | - | RSI (14) | 34.3 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.54 | Sales Q/Q | - | SMA20 | -18.73% ($5.07) | Beta | 1.03 | Target Price | $9.67 |
| Payout | - | Debt/Eq | 0.35 | Earnings | 2026/03/12 | SMA50 | -17.16% ($4.97) | Rel Volume | 3.09 | Prev Close | $4.67 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -15.19% ($4.86) | Avg Volume(3M) | 1.10M | Price | $4.12 |
| IPO | 2014/5/2 | Option/Short | Yes/Yes | Trades | 13599 | Volume | 3,399,683 | Change | -11.67% |
뉴스 로딩 중...